Biofrontera (BFRI) Receivables (2020 - 2026)
Biofrontera (BFRI) posted quarterly Receivables of $12.1 million for Q4 2025, up 13.9% year-over-year from $10.6 million in Q4 2024, and up 303.71% quarter-over-quarter from $3.0 million in Q3 2025.
Biofrontera (BFRI) Receivables (2020 - 2026) Analysis & Trends
Biofrontera's Receivables history runs 6 years deep, the most recent figure standing at $12.1 million for Q4 2025.
- In Q4 2025, Receivables rose 13.9% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at $12.1 million (up 13.9% YoY), while the FY2025 annual figure was $12.1 million, up 13.9% from the prior year.
- Receivables for Q4 2025 stood at $12.1 million, up from $3.0 million in the prior quarter.
- The five-year high for Receivables was $13.9 million in Q1 2022, with the low at $2.1 million in Q3 2021.
- The 5-year median for Receivables is $6.3 million (2023), against an average of $7.0 million.
- The sharpest annual moves came in 2021 and 2024: Receivables soared 277.96% in 2021, then tumbled 53.08% in 2024.
- Biofrontera's Receivables stood at $12.4 million in 2021, then decreased by 17.56% to $10.2 million in 2022, then dropped by 22.31% to $8.0 million in 2023, then jumped by 33.32% to $10.6 million in 2024, then grew by 13.9% to $12.1 million in 2025.
- Business Quant data shows BFRI's Receivables at $12.1 million in Q4 2025, $3.0 million in Q3 2025, and $4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.55 Mn |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.96 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 10.62 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.69 Mn |
| Dec 31, 2023 | 7.96 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 10.25 Mn |
| Sep 30, 2022 | 7.66 Mn |
| Jun 30, 2022 | 5.05 Mn |
| Mar 31, 2022 | 13.86 Mn |
| Dec 31, 2021 | 12.43 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Dec 31, 2020 | 3.29 Mn |